217 related articles for article (PubMed ID: 23882883)
1. Cardiac resynchronization therapy in a patient with amyloid cardiomyopathy.
Zizek D; Cvijić M; Zupan I
Acta Cardiol; 2013 Jun; 68(3):335-7. PubMed ID: 23882883
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the noninvasive strategies of cardiac amyloidosis.
Zhao L; Fang Q
Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
[TBL] [Abstract][Full Text] [Related]
3. Combined myocardial deformation to predict cardiac resynchronization therapy response in nonischemic cardiomyopathy.
Yang N; Liang ZG; Wang ZJ; Liu H; Chi C; Tian YF; Qi SH; Wang BY; Han W
Pacing Clin Electrophysiol; 2017 Sep; 40(9):986-994. PubMed ID: 28691201
[TBL] [Abstract][Full Text] [Related]
4. Cardiac amyloidosis: a practical approach to diagnosis and management.
Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
[TBL] [Abstract][Full Text] [Related]
5. The Role of Standard Echocardiographic Parameters in Endomyocardial Biopsy Proven Cardiac Amyloidosis.
Biočić S; Jurinjak SJ; Vincelj J; Barić D; Manojlović S; Brkljačić DD
Coll Antropol; 2015 Jun; 39(2):441-5. PubMed ID: 26753463
[TBL] [Abstract][Full Text] [Related]
6. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
7. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB.
Varma N; Manne M; Nguyen D; He J; Niebauer M; Tchou P
Heart Rhythm; 2014 Jul; 11(7):1139-47. PubMed ID: 24704570
[TBL] [Abstract][Full Text] [Related]
8. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy in ischemic vs nonischemic cardiomyopathy patients.
Abu Daya H; Alam MB; Adelstein E; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
Heart Rhythm; 2014 Apr; 11(4):614-9. PubMed ID: 24462657
[TBL] [Abstract][Full Text] [Related]
9. Understanding and recognizing cardiac amyloidosis.
McVeigh T; Tennyson C
JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
[TBL] [Abstract][Full Text] [Related]
10. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis.
Hamer JP; Janssen S; van Rijswijk MH; Lie KI
Eur Heart J; 1992 May; 13(5):623-7. PubMed ID: 1618203
[TBL] [Abstract][Full Text] [Related]
11. [Echocardiographic analysis in cardiac amyloidosis].
Hurrel C; Deriaz-Chessex S; Waeber G; Jeanrenaud X; Périard D
Praxis (Bern 1994); 2006 Jun; 95(24):977-81. PubMed ID: 16802507
[TBL] [Abstract][Full Text] [Related]
12. Amyloid cardiomyopathy.
Karafiatova L; Pika T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):117-127. PubMed ID: 28145535
[TBL] [Abstract][Full Text] [Related]
13. Improved coronary artery blood flow following the correction of systolic dyssynchrony with cardiac resynchronization therapy.
Fang F; Chan JY; Lee AP; Sung SH; Luo XX; Jiang X; Kwong JS; Sanderson JE; Yu CM
Int J Cardiol; 2013 Sep; 167(5):2167-71. PubMed ID: 22704862
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the diagnosis and management of cardiac amyloidosis.
Sher T; Gertz MA
Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Care of Patients with Cardiac Amyloidosis.
Itzhaki Ben Zadok O; Kornowski R
Acta Haematol; 2020; 143(4):343-351. PubMed ID: 32408301
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three-dimensional echocardiographic software packages for assessment of left ventricular mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy.
Aly MF; Kleijn SA; de Boer K; Abd El-Hady YA; Sorour KA; Kandil HI; van Rossum AC; Kamp O
Eur Heart J Cardiovasc Imaging; 2013 Jul; 14(7):700-10. PubMed ID: 23111693
[TBL] [Abstract][Full Text] [Related]
18. A metric for evaluating the cardiac response to resynchronization therapy.
Ge Y; Ruwald AC; Kutyifa V; McNitt S; Polonsky S; Klein H; Goldenberg I; Solomon SD; Foster E; Zareba W; Moss AJ
Am J Cardiol; 2014 Apr; 113(8):1371-7. PubMed ID: 24607029
[TBL] [Abstract][Full Text] [Related]
19. Cardiac manifestations of amyloid disease.
Rivera RJ; Vicenty S
Bol Asoc Med P R; 2008; 100(4):60-70. PubMed ID: 19400531
[TBL] [Abstract][Full Text] [Related]
20. Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options.
Alkhawam H; Patel D; Nguyen J; Easaw SM; Al-Sadawi M; Syed U; Zaiem F; Homsi M; Vittorio TJ
Acta Cardiol; 2017 Aug; 72(4):380-389. PubMed ID: 28705053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
